Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 71

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 71
---
4 and March 31, 2025:

    Schedule of unvested of restricted stock units 

    Number of Shares  
    Weighted Average Grant Date Fair Value Per Share 

    Unvested at June 30, 2024 
     40,291  
    $44.59 
  
    Issued 
     171,900  
     2.56 
  
    Vested 
     (74,643) 
     11.67 
  
    Canceled 
     (28,509) 
     6.67 
  
    Unvested at March 31, 2025 
     109,039  
    $10.81 

The total stock-based compensation expense from restricted
stock units for the three months ended March 31, 2025 and 2024 was approximately $321,000 and $336,000, respectively.  The total
stock-based compensation expense from restricted stock units for the nine months ended March 31, 2025 and 2024 was approximately $888,000
and $1.0 million, respectively.  

     17 

Stock Warrants

The following table summarizes the warrants activity during the nine months
ended March 31, 2025:

    Summary of warrants activity 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Life (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding and exercisable at June 30, 2024 
     1,932,029  
    $14.03  
     4.0  
    $- 
  
    Granted 
     10,181,640  
     1.65  
     4.8  
     - 
  
    Exercised 
     (2,502,967) 
     1.53  
     -  
     - 
  
    Expired 
     (10,138) 
     21.94  
     -  
     - 
  
    Outstanding and exercisable at March 31, 2025 
     9,600,564  
    $3.50  
     4.3  
    $- 

The table below shows the expiration of the warrants
outstanding as of March 31, 2025:

    Schedule of warrants outstanding